Ubiquitous chromatin opening element (UCOE)-mediated human coagulationFactor IX secretion by lentiviral transduction of human mesenchymalstem cells
Haemophilia B is a bleeding disorder caused by various mutations of the coagulation Factor IX gene (F9) resulting in qualitative or quantitative Factor IX protein (FIX) deficiency. Factor replacement therapy is the current standard of care. Cure may be possible in the near future by gene therapy —...
Main Authors: | Wong, Chi-kin, Felix., 黃子鍵. |
---|---|
Language: | English |
Published: |
The University of Hong Kong (Pokfulam, Hong Kong)
2013
|
Subjects: | |
Online Access: | http://hdl.handle.net/10722/192790 |
Similar Items
-
Expression of the human coagulation factor IX in the bone marrow mesenchymal stem cells
by: Azadehsadat Azadbakhsh, et al.
Published: (2014-05-01) -
Production of specific polyclonal antibodies anti-human factor IX
by: Daniel Gonçalves Chaves, et al.
Published: (2006-07-01) -
Purificación del factor IX recombinante expresado en leche de cerdas transgénicas Purification of recombinant factor IX expressed in milk of transgenic sows
by: Armando Cádiz Lahens, et al.
Published: (2006-08-01) -
Coagulation factor IX gene transfer to non-human primates using engineered AAV3 capsid and hepatic optimized expression cassette
by: Sandeep R.P. Kumar, et al.
Published: (2021-12-01) -
Prevention and Reversal of Antibody Responses Against Factor IX in Gene Therapy for Hemophilia B
by: Sushrusha eNayak, et al.
Published: (2011-12-01)